Bryan J. McMichael - Jun 13, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role: Title: Executive Vice President, Accounting, Corporate Controller and Principal Accounting Officer
Signature: /s/ McDavid Stilwell, as Attorney-in-Fact for Bryan J. McMichael
Stock symbol: CHRS
Transactions as of: Jun 13, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/15/2023, 04:41 PM
Previous filing: Mar 29, 2023
Next filing: Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CHRS	Stock Option (Right to Buy)	Award	$0	+30K		$0.00	30K	Jun 13, 2023	Common Stock	30K	$5.44	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Remarks:

Title: Executive Vice President, Accounting, Corporate Controller and Principal Accounting Officer